Myocardial bridges are prevalent after LAD CTO recanalization and their presence is associated with adverse outcomes, but the risk is driven mainly by stent extension into the bridged segment.
Key Findings
Results
Myocardial bridges were identified in 57.4% of patients after LAD CTO recanalization using intravascular ultrasound.
685 consecutive patients with LAD CTOs were analyzed retrospectively from January 2019 to December 2021.
MBs were identified in 393 of 685 patients (57.4%) on intravascular ultrasound.
All procedures were intravascular ultrasound-guided percutaneous coronary interventions.
Study design was retrospective.
Results
Stent extension into the bridged segment occurred in 44.3% of patients who had a myocardial bridge.
174 of 393 patients with MBs had stent extension into the bridged segment (44.3%).
The remaining 219 of 393 MB patients (55.7%) had the bridged segment spared from stenting.
This distinction formed the basis for subgroup comparisons of clinical outcomes.
Results
Patients with myocardial bridges had a higher 5-year incidence of major adverse cardiac events compared to those without myocardial bridges.
MACE rate was 16.1% in the MB group vs 8.9% in the no-MB group (P = 0.006).
MACE was defined as a composite of cardiac death, spontaneous myocardial infarction, and ischemia-driven revascularization.
Median follow-up was 5 years.
The higher MACE rate was driven primarily by more ischemia-driven revascularization in the MB group (15.1% vs 7.9%; P = 0.004).
Results
Stent extension into the myocardial bridge was associated with a significantly higher rate of MACE compared with sparing the bridged segment.
MACE rate was 21.4% when stent was extended into the MB vs 11.9% when the MB was spared (P = 0.0017).
This comparison was made within the subgroup of patients who had myocardial bridges identified.
The finding suggests that the surgical/interventional decision of whether to stent into the bridged segment substantially affects long-term outcomes.
Results
MACE rates did not significantly differ between patients with myocardial bridges spared from stenting and those without myocardial bridges.
MACE rate was 11.9% in MB-spared patients vs 8.9% in no-MB patients (P = 0.25).
This non-significant difference suggests that when stenting avoids the bridged segment, outcomes are comparable to patients without any MB.
This finding implies that the adverse prognosis associated with MBs is not inherent to the MB itself but is attributable to stenting within the bridged segment.
Results
Ischemia-driven revascularization was the primary driver of the increased MACE observed in patients with myocardial bridges.
Ischemia-driven revascularization occurred in 15.1% of MB patients vs 7.9% of non-MB patients (P = 0.004).
Cardiac death and spontaneous myocardial infarction components of MACE were not separately reported as significant drivers in the abstract.
The pattern was consistent with stent-related mechanical complications or restenosis in the bridged segment.
What This Means
This research suggests that a condition called a myocardial bridge — where a segment of a coronary artery runs through heart muscle instead of along its surface — is very common in patients who have had a blocked left heart artery (called a chronic total occlusion) opened up with a stent procedure. More than half of the 685 patients studied (57.4%) were found to have a myocardial bridge after their artery was reopened, which was detected using a specialized imaging tool inserted into the artery called intravascular ultrasound. The study followed patients for a median of five years and tracked serious heart-related events including cardiac death, heart attacks, and the need for additional procedures to restore blood flow.
The key finding is that having a myocardial bridge was associated with worse long-term outcomes overall, but the increased risk was almost entirely explained by whether or not the stent was placed into the bridged segment of the artery. When stents were extended into the myocardial bridge (which happened in about 44% of bridge cases), the rate of serious cardiac events was 21.4% — much higher than the 11.9% seen when the bridged segment was deliberately avoided. Importantly, patients whose bridged segment was spared from stenting had outcomes similar to patients who had no myocardial bridge at all (11.9% vs 8.9%, not statistically different).
This research suggests that identifying myocardial bridges with intravascular ultrasound before placing stents and then carefully avoiding extending the stent into the bridged tissue may be an important strategy to improve long-term outcomes in patients undergoing this type of procedure. The findings highlight that the myocardial bridge itself may not be inherently dangerous in this setting, but that placing a stent within it appears to drive the increased risk of needing repeat procedures or other heart events over time.
Geng Y, Zou T, Guan C, Zhang Y, Xu J, Liu H, et al.. (2026). Impact of Myocardial Bridges on Long-Term Outcomes After Left Anterior Descending Chronic Total Occlusion Recanalization.. JACC. Cardiovascular interventions. https://doi.org/10.1016/j.jcin.2026.06.020